I think investors do take insider buying as a good sign, and I think they especially wanted Boston Scientific to do it.

What the FDA seemed to be saying is that it doesn't know if Boston Scientific has a systemic, corporate-wide quality policy, and until it does the FDA will not permit the company to gain product approvals in adulterated plants.

Boston Scientific will do everything in its power to reach a deal with Guidant.

I haven't heard from a single Guidant shareholder who doesn't like the Boston Scientific deal.

The less time they give Boston Scientific, the worse it is for Boston Scientific. They have less time to react.